Airsculpt Technologies Business Summary

AirSculpt Technologies, Inc. (AIRS) operates as a specialized provider of minimally invasive body contouring procedures, generating revenue through a direct-to-consumer, fee-for-service model across its network of Elite Body Sculpture centers. The company’s primary business segment is direct medical procedure services, utilizing its proprietary, patented AirSculpt technology to perform fat removal and skin tightening without needles, scalpels, or general anesthesia. As of early 2026, the company has strategically pivoted to capture the burgeoning GLP-1 weight-loss market, positioning its services as essential post-medication skin tightening and body shaping solutions. AirSculpt competes directly with Sono Bello (Body Contour Centers, LLC), SBC Medical Group, and Ideal Image, as well as technology providers like InMode Ltd. Within this landscape, AirSculpt maintains a premium, luxury market position, commanding higher price points than traditional surgical liposuction by emphasizing superior aesthetic results and significantly reduced patient downtime. The company was founded by Dr. Aaron Rollins, the developer of the AirSculpt technique, who transitioned out of his role as Executive Chairman in late 2025. The current leadership team is led by Chief Executive Officer Yogi Jashnani, who joined in January 2025 with over 20 years of experience in aesthetics and retail, previously serving as Chief Commercial Officer of Ideal Image. Financial operations are managed by Chief Financial Officer Michael Arthur, appointed in January 2026, who brings a background as CFO of Inspirato and senior finance roles at CSC Generation and VF Corporation. The executive suite also includes Chief Digital Officer Brian Stetter, a performance marketing veteran. The company is supported by a board chaired by Mike Doyle, Managing Partner at Vesey Street Capital Partners and former CEO of Surgery Partners, reflecting a strong pedigree in scaling multi-site healthcare operations.